NorthWest Biotherapeutics Inc (NWBO): 🤷🏻‍♂&#xFE0...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

NorthWest Biotherapeutics Inc (NWBO)

Keep Last Read

Replies (1) Next 10 Prev Next

learningcurve2020

Send PM Follow Ignore

Followers	47
Posts	22926
Boards Moderated	0
Alias Born	09/16/2012

learningcurve2020

Re: learningcurve2020 post# 802744

Saturday, 12/13/2025 2:25:40 PM

Saturday, December 13, 2025 2:25:40 PM

🤷🏻‍♂️ AI: The Dr. Kevin Duffy who worked as the Vice President of Medical Affairs & External Collaborations for Northwest Biotherapeutics is no longer with the company. He held that position from September 2019 to approximately 2020.
His current primary roles are:
Operating Advisor at Shore Capital Partners, a private equity firm in Chicago, IL, a role he has held since May 2024.

Principal at an independent Life Science & Healthcare Consultant practice, based in Philadelphia, PA, a role he has held since October 2018.

Additionally, his professional profile indicates that from March 2021 to May 2024, he was the Chief Commercial Officer at KPS Life, a functional service provider in the biopharmaceutical industry.

But this guy isn’t a doctor?
https://www.linkedin.com/pulse/quality-data-how-resourcing-challenges-can-affect-clinical-duffy

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent NWBO News

Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments • AllPennyStocks.com • 01/13/2025 01:56:00 PM

More NWBO News

InvestorsHub NewsWire

Xalles Holdings Announces Management Changes • XALL • Jan 12, 2026 8:46 AM

One World Products Enters 2026 Positioned for Disciplined Growth as Isiah Enterprises • OWPC • Jan 8, 2026 12:22 PM

ConnectM Acquires 40% of Sun Solar, Strengthening Balance Sheet and Expanding National Solar & Storage Footprint in Multi-Billion Dollar U.S. Residential Solar & Storage Market • CNTM • Jan 7, 2026 9:00 AM

EVTV Executes Transformational AZIO AI Acquisition Framework at $3.00 Per Share • EVTV • Jan 6, 2026 7:00 AM

Fifty1 Labs, Inc. Clarifies Status Regarding Previously Announced Collaboration with LUNR Aerospace • FITY • Jan 5, 2026 1:00 PM

DRCR Enters a New Phase of Growth • DRCR • Dec 31, 2025 12:04 PM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow